| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533271A 5-amino levulic acid as photosensitizer in ligh chemical therapy and cpmbination of its ester and another photosensitizer, and their use in therapy |
| 09/29/2004 | CN1531971A Treating acute damage caused local tissue necrosis by combined monoclonal antibody |
| 09/29/2004 | CN1531939A Medicine for promoting wound healing |
| 09/29/2004 | CN1531934A Medicine for treating bromhidrosis |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168725C Formulation for protection against oxidative stress containing beozofuranone derivatives |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168489C Skin-haemorrhoids-clearing ointmenta nd preparing method thereof |
| 09/29/2004 | CN1168480C Externally applied ointment for treating burns and its prepn |
| 09/29/2004 | CN1168471C Medicine for treating recurrent aphtha and eczema |
| 09/29/2004 | CN1168468C Cream for treating allergic dermatitis, eczama and other skin inflammations |
| 09/29/2004 | CN1168449C Medicine against human papilloma virus |
| 09/29/2004 | CN1168447C Use of oxazolidinones for preparation of medicament for transdermal delivery |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797285 Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | US6797262 Film forming compositions for topical use and delivery of active ingredients |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081011A1 Immunomodulating heterocyclic compounds |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080449A1 Ultraviolet-induced active oxygen inhibitor |
| 09/23/2004 | WO2004080443A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | WO2004080437A1 Method of delivering substance by transdermal absorption, peeling agent to be used in delivery of substance by transdermal absorption, peeling apparatus and disposable pad for peeling apparatus |
| 09/23/2004 | WO2004069134A3 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | US20040187171 Expression vectors comprising nucleotide sequences coding cytokines for tissue specific expression and treatment of skin disorders |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186174 Hydroxydiphenyl ether compounds |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185485 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185120 cleanses and sterilizes the area, promotes rapid growth of new hair and tissue and reduces scarring; sterilized water, iodine and softening agents |
| 09/23/2004 | US20040185077 Applying dimethylaminoethanol, tyrosine, and sulfur compound such as lipoic acid, glutathione, sulfur, resorcinol, resorcinol monoacetate, and/or sulfacetamide; skin sensitivity; side effect reduction |
| 09/23/2004 | US20040185076 Treatment of acne using alkonolamine compositions |
| 09/23/2004 | US20040185067 Material delivery method by skin absorption, peeling agent used for material delivery by skin absorption, peeling device, and disposable pad for peeling device |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185026 Cosmetic compositions |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518763A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/22/2004 | EP1460120A1 Anion generating material and skin treating agent using the same |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459762A1 Preventives remedies for proliferative organ diseases chronic arthritic diseases hypertrophic scar or keloid |
| 09/22/2004 | EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458711A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 09/22/2004 | EP1458709A1 New process |
| 09/22/2004 | EP1458707A2 New compounds |
| 09/22/2004 | EP1458697A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458427A2 Compositions comprising collagen and metalloprotease inhibitors |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458395A1 New use |
| 09/22/2004 | EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458383A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |